Device type · LJS
Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LJS
General Hospital
Device class
Class II
FDA decisions since 2015
56
510(k), De Novo and PMA
Adverse event reports
3,333
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days
- Product code
- LJS
- Device class
- Class II
- Review panel
- General Hospital
- Regulation
- 21 CFR 880.5970
- Specialty
- Hospital Medicine & Nursing
- FDA record
- Classification database entry for LJS
Latest FDA decisions
The 8 newest of 56 since 2015.
K260080 · Decided Oct 9, 2026 · 270 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS) · Hospital Medicine & Nursing
K260929 · Decided Apr 17, 2026 · 28 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS) · Hospital Medicine & Nursing
K252373 · Decided Dec 16, 2025 · 139 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS) · Hospital Medicine & Nursing
K252792 · Decided Nov 17, 2025 · 76 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS) · Hospital Medicine & Nursing
K243458 · Decided Aug 1, 2025 · 266 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS) · Hospital Medicine & Nursing
K251212 · Decided Jul 1, 2025 · 74 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS) · Hospital Medicine & Nursing
K243484 · Decided May 29, 2025 · 202 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS) · Hospital Medicine & Nursing
- pilot TLS510(k)
K241587 · Decided Feb 26, 2025 · 268 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days (LJS) · Hospital Medicine & Nursing
Reports received
3,333
Received Nov 1, 2025 to Nov 19, 2026. Includes 13 of another or unstated type.
Malfunction reports
2,855
86% of reports
Injury reports
461
14% of reports
Death reports
4
0.1% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 190 | 22 | 0 | 0 |
| Jan 24 | 204 | 29 | 1 | 0 |
| Feb 24 | 235 | 31 | 1 | 0 |
| Mar 24 | 249 | 40 | 0 | 0 |
| Apr 24 | 233 | 34 | 0 | 0 |
| May 24 | 287 | 37 | 0 | 1 |
| Jun 24 | 329 | 30 | 0 | 1 |
| Jul 24 | 345 | 40 | 0 | 0 |
| Aug 24 | 367 | 24 | 0 | 0 |
| Sep 24 | 303 | 26 | 0 | 0 |
| Oct 24 | 400 | 50 | 2 | 0 |
| Nov 24 | 376 | 49 | 0 | 0 |
| Dec 24 | 462 | 55 | 0 | 2 |
| Jan 25 | 419 | 45 | 1 | 0 |
| Feb 25 | 413 | 53 | 0 | 0 |
| Mar 25 | 346 | 34 | 0 | 0 |
| Apr 25 | 334 | 43 | 0 | 0 |
| May 25 | 313 | 36 | 0 | 0 |
| Jun 25 | 277 | 34 | 1 | 0 |
| Jul 25 | 382 | 53 | 0 | 0 |
| Aug 25 | 290 | 61 | 2 | 0 |
| Sep 25 | 284 | 41 | 0 | 0 |
| Oct 25 | 272 | 31 | 0 | 0 |
| Nov 25 | 247 | 76 | 0 | 0 |
| Dec 25 | 301 | 35 | 0 | 0 |
| Jan 26 | 257 | 32 | 0 | 0 |
| Feb 26 | 298 | 39 | 0 | 0 |
| Mar 26 | 204 | 33 | 0 | 1 |
| Apr 26 | 222 | 38 | 1 | 0 |
| May 26 | 192 | 33 | 1 | 0 |
| Jun 26 | 245 | 33 | 1 | 0 |
| Jul 26 | 219 | 38 | 0 | 3 |
| Aug 26 | 176 | 38 | 0 | 2 |
| Sep 26 | 218 | 36 | 1 | 4 |
| Oct 26 | 276 | 30 | 0 | 3 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Fluid/Blood Leak1,320
- Material Deformation446
- Break222
- Fracture174
- Product Quality Problem118
- Contamination /Decontamination Problem117
- Packaging Problem104
- Adverse Event Without Identified Device or Use Problem100
- Leak/Splash85
- Material Frayed74
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions2,615
- Insufficient Information147
- Foreign Body In Patient131
- Swelling/ Edema94
- Pain92
- Extravasation70
- Thrombosis/Thrombus67
- Discomfort34
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available29
- Erythema26
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2803-2026 · Started Jun 15, 2026 · Posted by FDA Jul 24, 2026
Reason given: Catheters, indicated for short/long-term peripheral access to central venous system for the administration of fluids, medications, nutrients; and sampling, may experience leaking and/or cracking at the hub, which may lead to replacement, inability to flush/aspirate catheter, catheter occlusion, therapy interruption,...
Cause as FDA categorized it: Device Design
- L-Cath Midline S/L Catheter 20ga (3F) 1mm x 20cm, REF: 384620Open, Classified
Z-2804-2026 · Started Jun 15, 2026 · Posted by FDA Jul 24, 2026
Reason given: Catheters, indicated for short/long-term peripheral access to central venous system for the administration of fluids, medications, nutrients; and sampling, may experience leaking and/or cracking at the hub, which may lead to replacement, inability to flush/aspirate catheter, catheter occlusion, therapy interruption,...
Cause as FDA categorized it: Device Design
Z-2658-2026 · Started May 21, 2026 · Posted by FDA Jul 2, 2026
Reason given: Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Cause as FDA categorized it: Nonconforming Material/Component
Z-2659-2026 · Started May 21, 2026 · Posted by FDA Jul 2, 2026
Reason given: Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Cause as FDA categorized it: Nonconforming Material/Component
Z-2664-2026 · Started May 21, 2026 · Posted by FDA Jul 2, 2026
Reason given: Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Cause as FDA categorized it: Nonconforming Material/Component
Z-2665-2026 · Started May 21, 2026 · Posted by FDA Jul 2, 2026
Reason given: Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Cause as FDA categorized it: Nonconforming Material/Component
Z-2666-2026 · Started May 21, 2026 · Posted by FDA Jul 2, 2026
Reason given: Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Cause as FDA categorized it: Nonconforming Material/Component
Z-2378-2026 · Started Apr 21, 2026 · Posted by FDA Jun 13, 2026
Reason given: Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or...
Cause as FDA categorized it: Nonconforming Material/Component
Showing the 8 newest of 332 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.